20
Sanofi Chimie Gentilly Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
One of their significant offerings is Spiramycin, supported by a 'Withdrawn by Holder' Certificate of Suitability (CEP) with the number R1-CEP 2005-047 - Rev 00
This Chemical and TSE Type CEP, issued on September 06, 2012, remains in force until September 09, 2020, ensuring its reliability within the pharmaceutical industry.
Substance Number 293 associated with this CEP further emphasizes